• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化、过敏性肺炎和未分类间质性肺疾病中的肺部微生物群:一项初步试点研究。

Lung Microbiota in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Unclassified Interstitial Lung Diseases: A Preliminary Pilot Study.

作者信息

Man Milena Adina, Ungur Rodica Ana, Motoc Nicoleta Stefania, Pop Laura Ancuta, Berindan-Neagoe Ioana, Ruta Victoria Maria

机构信息

Department of Medical Sciences-Pulmonology, Faculty of Medicine, University of Medicine and Pharmacy, 8 Victor Babeș Street, 400012 Cluj-Napoca, Romania.

"Leon Daniello" Clinical Hospital of Pneumophtysiology, 400371 Cluj-Napoca, Romania.

出版信息

Diagnostics (Basel). 2023 Oct 9;13(19):3157. doi: 10.3390/diagnostics13193157.

DOI:10.3390/diagnostics13193157
PMID:37835899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10572521/
Abstract

(1) Introduction: Although historically, the lung has been considered a sterile organ, recent studies through 16S rRNA gene sequencing have identified a substantial number of microorganisms. The human microbiome has been considered an "essential organ," carrying about 150 times more information (genes) than are found in the entire human genome. The purpose of the present study is to characterize and compare the microbiome in three different interstitial lung diseases: idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis, and nondifferential interstitial lung disease. (2) Material and methods: This was a prospective cohort study where the DNA of 28 patients with ILD was extracted from the lavage and then processed using the standard technique of 16S RNA gene sequencing. In a tertiary teaching hospital in the northern, western part of Romania, samples were collected through bronchoscopy and then processed. (3) Results: The same four species were found in all the patients but in different quantities and compositions: , , and . was the most prevalent genus, followed by and . Statistically significant differences in the OUT count for the ten most abundant taxa were found for the genus: , , , , and . The comparative analysis showed a richer microbiota in patients with IPF, as shown by the alpha diversity index. (4) Conclusions: In interstitial lung diseases, the microorganisms normally found in the lung are reduced to a restricted flora dominated by the family. These changes significantly disrupt the continuity of the observed bacterial pattern from the oropharynx to the bronchial tree and lung, possibly impacting the evolution and severity of interstitial lung diseases.

摘要

(1) 引言:尽管从历史上看,肺一直被认为是一个无菌器官,但最近通过16S rRNA基因测序的研究已经鉴定出大量微生物。人类微生物组被视为一个“重要器官”,其携带的信息(基因)比整个人类基因组中的信息多约150倍。本研究的目的是对三种不同的间质性肺疾病:特发性肺纤维化(IPF)、过敏性肺炎和非特异性间质性肺疾病中的微生物组进行表征和比较。(2) 材料与方法:这是一项前瞻性队列研究,从28例间质性肺疾病患者的灌洗物中提取DNA,然后使用16S RNA基因测序的标准技术进行处理。在罗马尼亚北部和西部的一家三级教学医院,通过支气管镜收集样本,然后进行处理。(3) 结果:在所有患者中都发现了相同的四种物种,但数量和组成不同:[此处原文缺失具体物种名称]、[此处原文缺失具体物种名称]、[此处原文缺失具体物种名称]和[此处原文缺失具体物种名称]。[此处原文缺失具体属名]是最常见的属,其次是[此处原文缺失具体属名]和[此处原文缺失具体属名]。在十个最丰富的分类单元的OUT计数中,发现[此处原文缺失具体属名]、[此处原文缺失具体属名]、[此处原文缺失具体属名]、[此处原文缺失具体属名]和[此处原文缺失具体属名]属存在统计学显著差异。比较分析显示,如α多样性指数所示,IPF患者的微生物群更丰富。(4) 结论:在间质性肺疾病中,通常在肺中发现的微生物减少为以[此处原文缺失具体科名]科为主的受限菌群。这些变化显著破坏了从口咽到支气管树和肺所观察到的细菌模式的连续性,可能影响间质性肺疾病的演变和严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/f9f3a38b2bbb/diagnostics-13-03157-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/996363dcbb8a/diagnostics-13-03157-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/7be9ef8f3eb0/diagnostics-13-03157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/f77123b67470/diagnostics-13-03157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/b6249f6f34b7/diagnostics-13-03157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/c2073d4c2dc6/diagnostics-13-03157-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/f9f3a38b2bbb/diagnostics-13-03157-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/996363dcbb8a/diagnostics-13-03157-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/7be9ef8f3eb0/diagnostics-13-03157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/f77123b67470/diagnostics-13-03157-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/b6249f6f34b7/diagnostics-13-03157-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/c2073d4c2dc6/diagnostics-13-03157-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be0b/10572521/f9f3a38b2bbb/diagnostics-13-03157-g006.jpg

相似文献

1
Lung Microbiota in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Unclassified Interstitial Lung Diseases: A Preliminary Pilot Study.特发性肺纤维化、过敏性肺炎和未分类间质性肺疾病中的肺部微生物群:一项初步试点研究。
Diagnostics (Basel). 2023 Oct 9;13(19):3157. doi: 10.3390/diagnostics13193157.
2
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.慢性变应性肺炎的呼吸微生物群与特发性肺纤维化不同。
Am J Respir Crit Care Med. 2021 Feb 1;203(3):339-347. doi: 10.1164/rccm.202002-0460OC.
3
Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.特发性肺纤维化终末期肺部微生物组的地形异质性:肺器官培养物中的微生物组-2 研究(MiLEs-2)。
Thorax. 2021 Mar;76(3):239-247. doi: 10.1136/thoraxjnl-2020-214770. Epub 2020 Dec 2.
4
A cohort study of interstitial lung diseases in central Denmark.丹麦中部间质性肺疾病的队列研究。
Respir Med. 2014 May;108(5):793-9. doi: 10.1016/j.rmed.2013.09.002. Epub 2013 Sep 20.
5
Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.肺微生物组多样性受损可预测特发性肺纤维化的进展。
Respir Res. 2018 Feb 27;19(1):34. doi: 10.1186/s12931-018-0736-9.
6
Alveolar microbiota profile in patients with human pulmonary tuberculosis and interstitial pneumonia.肺泡微生物组在人肺结核和间质性肺炎患者中的特征。
Microb Pathog. 2020 Feb;139:103851. doi: 10.1016/j.micpath.2019.103851. Epub 2019 Nov 9.
7
Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?计算机断层扫描(CT)能区分过敏性肺炎和特发性肺纤维化吗?
AJR Am J Roentgenol. 1995 Oct;165(4):807-11. doi: 10.2214/ajr.165.4.7676971.
8
Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.慢性阻塞性肺疾病患者临床稳定期痰液微生物组与加重表型的相关性研究。
J Transl Med. 2021 Mar 23;19(1):121. doi: 10.1186/s12967-021-02788-4.
9
Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study.特发性肺纤维化患者的慢性过敏性肺炎:一项前瞻性病例队列研究。
Lancet Respir Med. 2013 Nov;1(9):685-94. doi: 10.1016/S2213-2600(13)70191-7. Epub 2013 Oct 21.
10
CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.血清、BAL 液和肺泡巨噬细胞培养上清液中的 CCL18 在间质性肺疾病中的作用。
Respir Med. 2013 Sep;107(9):1444-52. doi: 10.1016/j.rmed.2013.06.004. Epub 2013 Jul 5.

引用本文的文献

1
Role of gut microbes in acute lung injury/acute respiratory distress syndrome.肠道微生物在急性肺损伤/急性呼吸窘迫综合征中的作用。
Gut Microbes. 2024 Jan-Dec;16(1):2440125. doi: 10.1080/19490976.2024.2440125. Epub 2024 Dec 10.
2
Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.将微生物群特征与常见可变免疫缺陷中的疾病特征相联系:以肉芽肿性淋巴细胞间质性肺病为例
Biomedicines. 2024 Oct 1;12(10):2239. doi: 10.3390/biomedicines12102239.
3
Comparative Analysis of Gut Microbiota between Captive and Wild Long-Tailed Gorals for Ex Situ Conservation.

本文引用的文献

1
Genome-wide mapping of gene-microbe interactions in the murine lung microbiota based on quantitative microbial profiling.基于定量微生物谱分析的小鼠肺部微生物群中基因-微生物相互作用的全基因组图谱绘制。
Anim Microbiome. 2023 Jun 1;5(1):31. doi: 10.1186/s42523-023-00250-y.
2
The Lung Microbiome: A New Frontier for Lung and Brain Disease.肺部微生物组:肺部和脑部疾病的新领域。
Int J Mol Sci. 2023 Jan 21;24(3):2170. doi: 10.3390/ijms24032170.
3
Understanding respiratory microbiome-immune system interactions in health and disease.了解健康与疾病状态下呼吸道微生物群与免疫系统的相互作用。
圈养与野生中华斑羚肠道微生物群的比较分析,用于迁地保护
Microorganisms. 2024 Jul 12;12(7):1419. doi: 10.3390/microorganisms12071419.
4
The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review.肺微生物组在肺纤维化性间质性肺疾病中的作用——系统综述。
Biomolecules. 2024 Feb 20;14(3):247. doi: 10.3390/biom14030247.
Sci Transl Med. 2023 Jan 11;15(678):eabq5126. doi: 10.1126/scitranslmed.abq5126.
4
The dynamic lung microbiome in health and disease.健康与疾病中的动态肺部微生物组。
Nat Rev Microbiol. 2023 Apr;21(4):222-235. doi: 10.1038/s41579-022-00821-x. Epub 2022 Nov 16.
5
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.慢性阻塞性肺疾病患者与健康个体的肺部微生物群组成及支气管上皮基因表达:细菌16S rRNA基因测序和宿主转录组分析
Lancet Microbe. 2021 Jul;2(7):e300-e310. doi: 10.1016/S2666-5247(21)00035-5. Epub 2021 Apr 23.
6
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.特发性肺纤维化和其他间质性肺疾病中的肺微生物组。
Int J Mol Sci. 2022 Jan 17;23(2):977. doi: 10.3390/ijms23020977.
7
Performance of Conventional Urine Culture Compared to 16S rRNA Gene Amplicon Sequencing in Children with Suspected Urinary Tract Infection.常规尿液培养与 16S rRNA 基因扩增测序在疑似尿路感染患儿中的比较。
Microbiol Spectr. 2021 Dec 22;9(3):e0186121. doi: 10.1128/spectrum.01861-21.
8
Entering the second decade: FEBS Open Bio in 2022.进入第二个十年:2022年的《FEBS开放生物学》。
FEBS Open Bio. 2022 Jan;12(1):4-8. doi: 10.1002/2211-5463.13343. Epub 2021 Dec 20.
9
Development of a robust protocol for the characterization of the pulmonary microbiota.建立一个稳健的方案以用于肺部微生物组的特征分析。
Commun Biol. 2021 Feb 5;4(1):164. doi: 10.1038/s42003-021-01690-5.
10
The Lung Microbiome and Pneumonia.肺部微生物群与肺炎
J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S241-S245. doi: 10.1093/infdis/jiaa702.